By REUTERS
NYT Business
U.S. healthcare stocks could face more turbulence on Tuesday, after a bumpy early 2019, as top executives from some of the largest pharmaceutical companies are expected to get grilled in the U.S. Senate on the high cost of prescription drugs.
Published date: February 25, 2019 at 09:50PM
Reuters
New York Times article
No comments:
Post a Comment